Literature DB >> 8158108

Etiological role of hepatitis E virus in sporadic fulminant hepatitis.

S K Nanda1, K Yalcinkaya, A K Panigrahi, S K Acharya, S Jameel, S K Panda.   

Abstract

Non-A, non-B hepatitis viruses have been implicated as the etiological agent(s) in up to 60% of patients with fulminant hepatitis. These agents are reported to induce a higher mortality than other causes of fulminant hepatitis. Hepatitis E virus (HEV) and hepatitis C virus (HCV) at present constitute the major identifiable non-A, non-B hepatitis agents. Of these, HEV has been established as the sole cause of epidemic hepatitis in Afro-Asian countries, and fulminant hepatitis has been recorded during such epidemics. However, in sporadic cases, the etiological role of HEV in fulminant hepatitis has remained uncertain. The role of HCV in acute liver disease and fulminant hepatitis remains unclear. The present study was undertaken to investigate the association of HEV and HCV in patients with fulminant hepatitis by direct detection of the viral genome using reverse transcription-polymerase chain reaction (RT-PCR). Serum samples from 50 serologically identified non-A, non-B fulminant hepatitis cases negative for cryptic hepatitis B virus (HBV) infection examined via PCR were tested for HEV and HCV RNA using RT-PCR. For HEV primers from the nonstructural region (ORF-1) were used, and for HCV primers from the highly conserved 5' untranslated regions were used. The products were analysed using agarose gel electrophoresis and confirmed by hybridisation with radiolabelled internal oligonucleotide probes. HEV was detected in 31 (62%) of the 50 fulminant non-A, non-B hepatitis cases. In 18 (36%) cases, HCV RNA was detected. In 11 (22%) of the HCV cases, the HEV genome was also amplified. In 20 (40%) cases, HEV was detected alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158108     DOI: 10.1002/jmv.1890420207

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

1.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

2.  Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients.

Authors:  Saurabh Kedia; Deepak Gunjan; Ujjwal Sonika; Soumya Jagannath Mahapatra; Baibaswata Nayak; Harpreet Kaur; Subrat Kumar Acharya
Journal:  Dig Dis Sci       Date:  2017-01-27       Impact factor: 3.199

3.  A 7-day profile of oxidative stress and antioxidant status in patients with acute liver failure.

Authors:  Vikram Bhatia; Payal Bhardwaj; Jessina Elikkottil; Jyoti Batra; Anoop Saraya
Journal:  Hepatol Int       Date:  2008-09-16       Impact factor: 6.047

4.  Overview of Hepatitis E Virus.

Authors:  Susan Skidmore
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

5.  Predictive value of arterial ammonia for complications and outcome in acute liver failure.

Authors:  V Bhatia; R Singh; S K Acharya
Journal:  Gut       Date:  2005-07-15       Impact factor: 23.059

Review 6.  New perspectives on hepatitis E.

Authors:  Kenneth C Hyams
Journal:  Curr Gastroenterol Rep       Date:  2002-08

7.  Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Masahiro Azuma; Eiji Kusano; Tatsuya Aikawa; Takao Shibayama; Yasuyuki Yazaki; Hitoshi Mizuo; Jun Inoue; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

Review 8.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

9.  An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity.

Authors:  S K Panda; S K Nanda; M Zafrullah; I H Ansari; M H Ozdener; S Jameel
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis.

Authors:  R K Dhiman; A K Seth; S Jain; Y K Chawla; J B Dilawari
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.